Great Expectations: "I'm Losing 25% of My Weight No Matter What You Say"

Journal of Consulting and Clinical Psychology

Volumn 71, Issue 6, 2003, Pages 1084-1089

  Wadden, Thomas A ^a   Womble, Leslie G ^a   Sarwer, David B ^a   Berkowitz, Robert I ^a   Clark, Vicki L ^a   Foster, Gary D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG POTENCY; EXPECTATION; FEMALE; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; INTERVIEW; OBESITY; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VERBAL COMMUNICATION; WEIGHT REDUCTION;

ADULT; APPETITE DEPRESSANTS; COMBINED MODALITY THERAPY; CYCLOBUTANES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; MIDDLE AGED; MOTIVATION; OBESITY; PATIENT EDUCATION; SET (PSYCHOLOGY); WEIGHT LOSS;

EID: 0344064260     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0022-006X.71.6.1084     Document Type: Article

References (13)

1. Abbott Laboratories. (2001). MERIDIA (sibutramine hydrochloride monohydrate): Prescribing information. Physician's desk reference. Abbott Park, IL: Drug Information Services Group.
2. Blackburn, G. L. (1995). Effect of degree of weight loss on health benefits. Obesity Research, 3, 211S-216S.
3. Brownell, K. D., & Wadden, T. A. (1998). The LEARN Program for Weight Control: Special Medication Edition. Dallas, TX: American Health Publishing,
4. Diabetes Prevention Program Research Group. (2002). Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346, 393-403.
5. Foster, G. D., Wadden, T. A., Vogt, R. A., & Brewer, G. (1997). What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes. Journal of Consulting and Clinical Psychology, 65, 79-85.
6. Jeffery, R. W., Wing, R. R., & Randall, R. M. (1998). Are smaller weight losses or more achievable weight loss goals better in the long term for obese patients? Journal of Consulting and Clinical Psychology, 66, 641-645.
7. Klem, M. L., Wing, R. R., McGuire, M. T., Seagle, H. M., & Hill, J. O. (1997). A descriptive study of individuals successful at long-term maintenance of substantial weight loss. American Journal of Clinical Nutrition, 66, 239-246.
8. National Institutes of Health, National Heart, Lung, and Blood Institute. (1998). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. Obesity Research, 6(Suppl.), 5-210.
9. Wadden, T. A., Berkowitz, R. I., Sarwer, D. B., Prus-Wisniewski, R., & Steinberg, C. M. (2001). Benefits of lifestyle modification in the pharmacologic treatment of obesity: A randomized trial. Archives of Internal Medicine, 161, 218-227.
10. Wadden, T. A., & Butryn, M. L. (in press). Behavioral treatment of obesity. Endocrinology and Metabolism Clinics of North America.
11. Wadden, T. A., Womble, L. G., Stunkard, A. J., & Anderson, D. A. (2002). Psychosocial consequences of obesity and weight loss. In T. A. Wadden & A. J. Stunkard (Eds.), Handbook of obesity treatment (pp. 144-169). New York: Guilford Press.
12. Wing, R. R. (2002). Behavioral weight control. In T. A. Wadden & A. J. Stunkard (Eds.), Handbook of obesity treatment (pp. 301-306). New York: Guilford Press.
13. Yanovski, S. Z., & Yanovski, J. (2002). Obesity. New England Journal of Medicine, 346, 591-602.